19Jul
13Jul
D&D Pharmatech’s US unit to work with NIH, Johns Hopkins for Parkinson’s research
Neuraly, a U.S. subsidiary of D&D Pharmatech, has announced a collaboration with the National Institute on Aging (NIA) under the National Institutes of Health (NIH) and Johns Hopkins University School of Medicine to advance biomarker research using serum samples from patients involved in the phase 2 clinical trial of NLY01, a treatment for Parkinson's disease. NLY01, a long-acting GLP-1 receptor agonist, is being developed as a therapeutic for neurodegenerative diseases, including Parkinson's disease. he drug recently completed a global phase...
03Jul
Wasabi Technologies partners with Retelit to expand storage services in Italy
Cloud storage provider Wasabi Technologies has struck up a new partnership with technology infrastructure provider Retelit to expand cloud storages services in Italy. As part of the strategic partnership agreement, Retelit will sell Wasabi’s hot cloud storage as part of its core offering, while Wasabi will open the first Italian storage region in Milan. Scheduled to be operational in Q3 2024, the new region will be deployed in the newest hyper connected data center within Retelit’s Avalon Campus, Avalon 3,...
26Jun
EarthGrid Breaks Through on Major Milestones
EarthGrid Public Benefit Corporation (PBC), a plasma boring technology and development company, revealed today that their tunnel boring robot (TBR) has successfully completed several field tests at scale through some of the toughest tunneling geologies in the world. Additionally, the company is debuting its first-of-its-kind Plasma Excavation System (PES) featuring two plasma torches. These developments in tandem mark a significant step forward in the viability, efficiency and capabilities of the tunnel boring robot. This development announcement follows on the heels...
26Jun
Xeno Biosciences Starts Phase 1b Proof-of-Concept Study in Obesity
Xeno Biosciences Inc., a clinical stage drug discovery and development company advancing therapeutics for the treatment of obesity and metabolic diseases, announced today initiation of Phase 1b clinical study which is designed to provide proof-of-concept weight loss results, along with safety and tolerability, using an optimized formulation of the drug candidate XEN-101, in obese adults. The trial is expected to have top line results by the end of the year. The Phase 1b study is a double blinded, randomized, placebo...
18Jun
Dr. Linda Rhodes Joins Akston Biosciences’ Board of Directors
Akston Biosciences Corporation, dedicated to accelerating the biologics revolution in Animal Health, today announced the appointment of Linda Rhodes, VMD, PhD to its Board of Directors. Dr. Rhodes brings Akston thirty years of experience in the animal health industry as a scientist, senior executive, and board member. Dr. Rhodes said, “I enjoy working with early-stage companies that have innovative solutions for animal health unmet needs. Akston combines a track record of inventing pioneering new therapies with the in-house capabilities critical...
15Jun
Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute
Xylyx Bio, Inc., a regenerative medicine company developing groundbreaking solutions for tissue and organ modeling and repair, announced today that it has been awarded a Small Business Innovation Research (SBIR) Fast-Track grant from the National Cancer Institute of the National Institutes of Health (NIH) to advance commercial development of its InMatrico® disease modeling and drug testing platform to help scientists discover and test drug candidates for metastatic breast cancer. Xylyx Bio's InMatrico® metastatic breast cancer cell-based assay platform aims to...
04Jun
Meet man who sold his house to build company, now has annual turnover of Rs 600 crore, his business is…
Many people achieve great success through hard work, and one such individual is Rahul Singh from Chhattisgarh, who launched a company named EcoSoul Home by selling his house. This company produces eco-friendly products from materials like tree leaves and bamboo. Today, the company's turnover is nearly Rs 600 crore. Rahul is not only helping to save the environment but is also rapidly growing his business. While working for a company in the US, Rahul met Arvind Ganesan. Together, they founded...
21May
Cloud Innovators: Boston Bruins Tap Wasabi, Data Innovation to Transform Hockey
Wasabi Technologies, the hot cloud storage company, launched its new Cloud Innovators series which explores the ways hot cloud storage is shaping the future of technology for the innovative thought leaders and iconic brands Wasabi partners with. The first episode features Josh Carley, vice president of technology for TD Garden and the Boston Bruins. Read more >>
10May